Navigation Links
Mylan Launches Thiamine Hydrochloride Injection
Date:6/28/2012

PITTSBURGH, June 28, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its Mylan Institutional business has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for preservative-free Thiamine Hydrochloride Injection, 100 mg/mL, packaged in 200 mg/2 mL multiple-dose vials. This product is indicated for the treatment of thiamine deficiency.

Thiamine Hydrochloride Injection, 100 mg/mL, had U.S. sales of approximately $18.6 million for the 12 months ending March 31, 2012, according to IMS Health. Mylan is shipping this product, presented in 25-vial packs, immediately.

Currently, Mylan has 169 ANDAs pending FDA approval representing $83.9 billion in annual sales, according to IMS Health. Thirty-seven of these pending ANDAs are potential first-to-file opportunities, representing $25.6 billion in annual brand sales, for the 12 months ending Dec. 31, 2011, according to IMS Health.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service a habit, do what's right, not what's easy and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately one-third of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 150 countries and territories. Our workforce of more than 18,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around th
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mylan Launches Generic Version of Zyprexa® Tablets
2. Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva
3. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
4. Mylan Launches Generic Lipitor® in Five European Countries
5. Mylan Launches Generic Version of Plavix® Tablets
6. Mylan Sponsors Drug Store News and Pharmacist Society to Provide a New Business Networking Platform for Pharmacy Schools and Students
7. Mylan Launches Generic Version of Viramune® Tablets
8. Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy
9. Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovions Brovana® Product
10. Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex®
11. Mylan Launches Generic Version of Lipitor®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 25, 2015 Research and Markets ... of the "Research and Future Development Trend Forecast ... offering. At present, there are 35,600 dialysis ... concentration ratio are large due to the different regional ... dialysis centers in other Asian countries are operated by ...
(Date:5/27/2015)... 2015  Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... pain, announced today that it will present at the ... 2015 at the Luxe Sunset Hotel in ... presentation by Michael Becker , Relmada,s senior vice ... begin at 2:00 p.m. PT/5:00 p.m. ET. A live ...
(Date:5/27/2015)... , May 27, 2015  Halozyme Therapeutics, Inc. ... (Ventana), a member of the Roche Group, announced today ... and for Ventana to ultimately commercialize, a companion diagnostic ... The Ventana assay will be used ... a glycosaminoglycan – a chain of natural sugars distributed throughout ...
Breaking Medicine Technology:China Dialysis Market Report: Research and Future Development Trends and Forecasts 2015-2020 2Relmada Therapeutics to Present at the 2015 LD Micro Invitational Conference 2Relmada Therapeutics to Present at the 2015 LD Micro Invitational Conference 3Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 2Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 3Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 4Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment 5
... SAN DIEGO , Jan. 20, 2010 Amylin Pharmaceuticals, ... for the fourth quarter and full year 2009 on Wednesday, January ... . Daniel M. Bradbury , Amylin,s president and chief executive officer, ... financial results for the fourth quarter and year ended December 31, ...
... 20 Roper Industries, Inc.   (NYSE: ... of 2009, ended December 31, 2009 , will be released before ... call to discuss these results has been scheduled for 8:30 AM ... be accessed via webcast or by dialing +1 888-539-3679 (US/ Canada ) ...
Cached Medicine Technology:Amylin Pharmaceuticals to Webcast Year-End Financial Results 2
(Date:5/27/2015)... 2015 CRN International, the radio marketing ... new Chief Financial Officer. , Prinner most recently was ... that held financial/operational executive positions at telecom and technology ... Communications, Utilicom, and SNET. His accounting and consulting ... CRN, Prinner will be able to tap into his ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Danish scientists ... line” biomarkers that have the potential to help in ... to read the full story that has just ... University in Aalborg, Denmark say new biomarkers found in ... outlook for patients with malignant mesothelioma . ...
(Date:5/27/2015)... Widely regarded as being Arizona’s ... adults ages 18 to 40, Scottsdale Recovery Center ... Joint Commission. The announcement follows SRC’s recent ... entailing a number of added clinical services, among ... treatment program in lieu of a growing national ...
(Date:5/27/2015)... MA (PRWEB) May 27, 2015 Join us ... . This family-friendly event seeks to spread awareness of brain ... promoting an overall appreciation for life. , The 3rd ... off from the Braham Area Community Center located at 655 ... Registration opens at 8:00am, while the 5K Walk/Run kicks off ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 This year, ... health awareness campaign and encouraging those affected to seek assistance ... Mental Health (NAMI), one in five children, ages 13 ... illness. Additionally, 50% of all cases of mental illness within ... suggesting, it is essential to seek help before reaching a ...
Breaking Medicine News(10 mins):Health News:CRN International Names New Chief Financial Officer 2Health News:New Report Highlights Current and Emerging Biomarkers for Mesothelioma, According to Surviving Mesothelioma 2Health News:Arizona Drug Treatment Center SRC Announces JCAHO Accreditation 2Health News:Renowned Brain Aneurysm Foundation to Benefit from 3rd Annual Appreciation for Life 5K Walk/Run in Braham, MN Being Held on June 6th 2Health News:The Glenholme School Observes Mental Health Awareness Month 2Health News:The Glenholme School Observes Mental Health Awareness Month 3
... similar ailment experienced these subtle attacks, scientists say , , ... genetically altered to develop an Alzheimer,s-like illness undergo "silent" ... College of Medicine, the seizures may explain why some ... The seizures observed in the mice would not be ...
... Tenn., Sept. 5 NFL great Eddie George,believes there,s ... 40 to stay fit and,prevent disease -- and more ... to,undertake a six month experiment to see if he,s ... such stars as Donovan McNabb, Jerome Bettis,Reggie Wayne and ...
... 5 Your child has been,playing outside. His hands are ... a nightly ritual in millions of homes all over the ... washing isn,t just about dirt. The U.S. Centers for Disease,Control ... important,things children can do to help stay healthy. According ...
... Shipcom Wireless, Inc., a leading,global provider of ... mobility and RFID solutions, announced,today that it will ... second,generation Electronic Product Code (EPC Gen. 2) RFID ... Group,s Future Store Initiative. The Future Store ...
... Fitness Systems,based in Gaithersburg, Maryland, has been named ... which just released its,2007 Inc. 5000 ranking of ... be found on Inc. magazine,s website at ... Heartline achieved a 65.6% growth rate in ...
... Close Up TV News recognizes Dr.,David Cohen of ... and patient care. To view the Multimedia News ... and highly respected cardiologist for over 20 years,Dr. Cohen ... wide variety of new,catheter-based therapies for vascular diseases. Circulatory ...
Cached Medicine News:Health News:Alzheimer's Patients May Suffer 'Silent' Seizures 2Health News:Mothers Know Best: NFL Moms Team With Eddie George to Showcase a Better Way to a Healthier Lifestyle 2Health News:When Should Children Wash Their Hands? 2Health News:Shipcom Partners With DOKUMENTA for METRO's Future Store Initiative 2Health News:Shipcom Partners With DOKUMENTA for METRO's Future Store Initiative 3Health News:Heartline(R) Fitness Systems Named to Inc. Magazine's Inaugural List of the 5000 Fastest Growing Private Companies in U.S.... 2Health News:Video: Circulatory Care of New Jersey 2
The SJM Sguin annuloplasty ring, a semi-rigid ring, is constructed of a one-piece solid core of ultra-high-weight polyethylene enclosed in a knitted polyester sewing cuff....
Diagnostic and laboratory test reference. Get help with test preparation, interpretation, follow-up, and reimbursement....
... HIPAA-compliant wireless technology that makes fully ... and personnel a reality. This advance ... or levels means a ... shorter hospital stays and improved outcomes. ...
... Focus from Thermo Labsystems was designed specifically ... Advanced features such as the new fast ... on microvolumes help to define this as ... The new interchangeable handle plate offers a ...
Medicine Products: